Minicircles are a new form of supercoiled DNA molecule for enhancer/promoter. Comparing maximal differences, these nonviral gene transfer which have neither bacterial origin of minicircles gave 2.5 to 5.5 times more reporter gene replication nor antibiotic resistance marker. They are thus activity than the unrecombined plasmid in the NIH3T3 cell smaller and potentially safer than the standard plasmids line and rabbit smooth muscle cells. Moreover, injection in currently used in gene therapy. They were obtained in E.
Introduction
Minicircles are new supercoiled DNA molecules for nonviral gene transfer, which have neither bacterial origin of replication nor antibiotic resistance gene. 1 Minicircles are obtained in E. coli by att site-specific recombination mediated by the phage integrase. Minicircles may contain no more than a eukaryotic expression cassette and the attR fragment resulting from the attP/attB recombination event. Thus they are a nondisseminating genetic material for nonviral gene therapy. Furthermore, minicircles carry only short bacterial sequences. Such sequences may cause undesirable effects such as the production of antibodies against bacterial proteins expressed from cryptic upstream eukaryotic expression signals, 2 changes in eukaryotic gene expression caused by the antibiotic resistance marker, 3 and immune responses to CpG sequences. [4] [5] [6] In this study, we have produced new minicircles carrying the luciferase or ␤-galactosidase reporter gene under the control of the strong human cytomegalovirus immediate-early enhancer/promoter. The efficiency of gene transfer with these minicircles was compared with that of the corresponding unrecombined plasmid or larger plasmids, both in vitro in transformed primary cells, and in vivo, in muscle and experimental tumors. Our results suggest that the use of minicircles may be 
Results
Construction and production of CMV luc+ and CMV ␤-gal minicircles The plasmids pXL3186 and pXL3187 contain the ColE1 origin of replication (ie they are derived from pBR322), a kanamycin-resistance gene, and, in the same orientation, the 385 bp attP site of phage and the 31 bp E. coli minimal attB sequence 7 ( Figure 1 ). In pXL3186, the cDNA encoding the modified firefly luciferase was inserted between the attP and attB sites. In this 5.5 kb construct, the reporter gene is under the control of the CMV enhancer/promoter, fused to the herpes simplex virus thymidine kinase gene 5′ untranslated leader. The 5.5 kb construct also contains a polyadenylation signal from the bovine growth hormone gene. In pXL3187 the ␤-galactosidase gene was cloned between the attP and attB sites. In this 7.3 kb construct, the reporter gene is under the control of the CMV enhancer/promoter and has an SV40 polyadenylation signal.
Recombination was achieved by thermal induction of integrase at 42°C in E. coli D1210HP. 8 E. coli D1210, which lacks the thermosensitive lysogen, was used as a control. Phage integrase mediates site-specific recombination between the attP and attB sites. The two recombination sites are in the same orientation on the same replicon. Recombination results in the excision of a supercoiled minicircle carrying only the eukaryotic gene expression cassette and the recombinant attR site. 9 Int- mediated recombination on pXL3186 produced a 2.8 kb minicircle with a CMV luc+ cassette, whereas a 4.6 kb minicircle containing a CMV ␤-galactosidase cassette is obtained after recombination on pXL3187 ( Figure 1 ). In both cases, a 2.7 kb derivative plasmid containing the origin of replication, the antibiotic marker gene and the recombinant attL site was generated. Extrachromosomal DNA from D1210HP pXL3186 and D1210HP pXL3187 cultures shifted from 30°C to 42°C was subjected to electrophoresis and all the expected bands were detected ( Figure 2 ). There was no recombination in D1210 pXL3186 or D1210 pXL3187, indicating that the recombination was Int-mediated. There was unrecombined plasmid present in each case, showing that the reaction was not complete. Dimers and nicked form of each molecule were also visible.
Supercoiled molecules obtained by recombination were digested either with BglII and AlwNI (D1210HP pXL3186) or with BglII and MscI (D1210HP pXL3187), which cut only the miniplasmid and the unrecombined plasmid, but not the corresponding minicircle (Figure 1 ). Supercoiled molecules were then isolated by CsCl ethidium bromide (CsCl-EtBr) density gradient centrifugation. Agarose gel electrophoresis showed that the minicircles obtained were not contaminated with miniplasmid or the starting plasmid (Figure 3 fragment of pXL2776, which is specific for the miniplasmid or unrecombined plasmid backbone; (2) the 2.6 kb StuI-EcoRI fragment of pXL3072, which is specific for the CMV luc+ minicircle; and (3) the 4.3 kb EcoRI-HindII fragment of pXL3187 which is specific for the CMV ␤-gal minicircle.
Minicircle dimers and relaxed minicircle copurified with the minicircle (Figure 3 ).
Comparison of in vitro transfection with minicircle and unrecombined plasmid NIH3T3 fibroblasts were transfected using the cationic lipid RPR120535 complexed with either CMV luc+ pXL3186 or the derived CMV luc+ minicircle. For each cationic lipid:DNA ratio, luciferase expression was significantly higher with the minicircle than with the original plasmid (Figure 4a) .
A similar result was obtained in NIH3T3 with the CMV ␤-gal minicircle (Figure 4c ). The minicircle also gave significantly more expression when transfecting primary cells, such as rabbit aortic smooth muscle cells (Figure 4b and d). These in vitro experiments were reproduced between two and three times in triplicate in each cell line.
In vivo minicircle transfer
Reporter gene expression was studied after injection in vivo into either mouse cranial tibial muscle or experimental tumors obtained by implantation of human head and neck carcinoma TU182 cells into nude mice. In vivo gene transfer is a multifactorial process, depending on several parameters such as the number of expression cassettes, total amount of DNA and volume injected, as well as the presence of inflammatory contaminants. As a consequence, in vivo gene expression is rarely dependent in a linear fashion upon the quantity of reporter gene expression cassette administered. Therefore, in order to make a head to head comparison of different constructs as the tool for in vivo gene transfer, we injected the same quantity (10 g) of each construct in the same volume (25 l).
The SV40 luc expression cassette was injected into mouse cranial tibial muscle in a pXL3067 (15.3 kb), unrecombined pXL2650 (7.4 kb), pGL2 control (6 kb) or minicircle (3.4 kb) backbone. Luciferase gene expression was consistently higher with the minicircle, up to 32 times higher than pXL3067, 24 times higher than pXL2650 and seven times higher than with pGL2 control (Figure 5a ). Similar results were obtained with a CMV ␤-gal expression cassette, where the minicircle (4.6 kb) gave ␤-galactosidase activity 13 times higher than that of the corresponding unrecombined plasmid pXL3187 (7.3 kb) ( Figure 5b ). With a CMV luc+ expression cassette, the minicircle (2.8 kb) gave luciferase activity up to 50 times higher than that of the unrecombined pXL3186 (5.5 kb) ( Figure 5c ). Gene expression was also dependent on the backbone used in the TU182 carcinoma system. For the SV40 expression cassette, the efficiency of gene transfer was 40 times higher with the minicircle than with the unrecombined plasmid pXL2650 and eight times higher with the minicircle than with the pGL2 control ( Figure 6 ).
Comparative histological analysis of intramuscular gene transfer using the CMV luc+ minicircle and unrecombined pXL3186 Anterior tibial muscles injected with the CMV luc+ minicircle or pXL3186, as previously described, were used for a comparative histological study ( Figure 7 and Table 1 ). Only myofibers expressed the transgene in anterior tibial muscle. They were located in small areas of the injected muscle, around the injection site. The intensity of luciferase staining differed greatly between transfected myofibers, from weak discrete labeling to strong diffuse labeling. This labeling was restricted to the sarcoplasm of the myofibers. The percentage of transfected myofibers per muscle was significantly higher for injection with CMV luc+ minicircle, with minimal levels of muscle damage, than for injection with pXL3186.
Discussion
Minicircles consist of a minimal DNA vector with no origin of replication or resistance marker. In this study, we have demonstrated that minicircles give higher levels of gene transfer in vitro and in vivo in the case of intramuscular and intratumoral transfer of naked DNA. We used several cell types and tissues and different reporter genes and promoters, demonstrating the potential of the minicircle as a DNA vehicle for nonviral gene transfer. Histological analysis showed that the percentage of transfected myofibers was markedly higher with the CMV luc+ minicircle than with the unrecombined plasmid pXL3186. The percentage of transfected myofibers, obtained with only 10 g of the CMV luc + minicircle, was similar to that previously reported in an independent study with 50 g of a standard CMV reporter gene construct. 10 The topology of transfected DNA has a major effect on gene transfer efficiency. 11 However, our preparations of DNA molecules, investigated by agarose gel electrophoresis, appeared to contain similar ratios of relaxed and supercoiled molecules, so DNA topology is thus unlikely to account for the differences in reporter gene expression observed. On the other hand, transgene expression has been shown to be affected by plasmid DNA contaminants such as lipopolysacharide (LPS). In our protocol, minicircles could have increased level of purity, due to the fact that they were submitted to one more choride-cesium protocol purification than parental plasmid. This could partly explain the increased expression observed with minicircle. However, we have verified that plasmid and minicircle preparation led to a similar low level of endotoxin. Finally, a complete assessment of the potential of the minicircle backbone over a classical plasmid backbone, requires, in the future, extensive studies at different DNA dose and different mode of administration such as gene gun.
In vitro, the expression levels for vectors carrying the same reporter gene expression cassette suggest (especially in Figure 5a ) an inverse relationship between the size of the DNA vector and the efficiency of reporter gene expression. Limited nonviral gene delivery in vivo, in terms of transfection efficiency, has been attributed to low bioavailability of the gene to the target cell.
12 DNA bioavailability involves: (1) diffusion of DNA into the tissue; (2) entry of DNA through the cell membrane; (3) DNA diffusion into the cytoplasm; and (4) DNA entry into the nucleus of quiescent post-mitotic cells. The first and third points are diffusion steps, which depend on the physicochemical properties of DNA, such as its diffusion coefficient, which is inversely proportional to its molecular weight. 13 Moreover, in muscles, the extracellular matrix, principally the epimysium and endomysium, act as a size exclusion barrier, 14 suggesting that the size of DNA molecules may have a major effect on the diffusion of plasmids into the myofibers. 15 Recent studies seem to show that endocytosis is the major mechanism involved in the entry of DNA-cationic lipid complexes through the cell membrane in vitro. 16, 17 This could also be the case for entry of naked DNA into muscle in vivo, after specific interactions between DNA and T-tubules or caveolae. 14, 15 This step is limited by particle size: for example, liposomes larger than 200 nm in diameter are not efficiently taken up by the endocytic pathway (see for review Gao and Huang 18 ). Movement of DNA from the cytoplasm to the nucleus through the nuclear membrane is described as the more critical step for successful gene expression. 17 It has been shown that the rate of protein transport to the nucleus is influenced by the number of nuclear localization sequences in the protein, and most importantly, by the Muscle fibers were removed 7 days after injection with CMV luc+ minicircle or pXL3186. The total number of cranial tibial myofibers is estimated to be 2237. 35, 36 n, total number of treated muscles; control, muscle injected with 150 mm NaCl.
Figure 7 Comparative histological study of mouse muscle transfected with CMV luc+ minicircle or pXL3186. Histological sections of cranial tibial muscles of C57BL6 mice, 1 week after injection of CMV luc+ minicircle (a, b and c) or of unrecombined pXL3186 (d and e). Sections were stained for luciferase expression by immunohistochemistry (brown labeling) and counterstained with haematoxylin (purple labeling). (b and c) High magnification of (a). (e) High magnification of (d). Arrows indicate regenerated myofibers and inflammatory foci. Original magnification: (a) ×50; (d)
size of the protein. 17, [19] [20] [21] It is also conceivable that the size of transfected DNA molecules might determine their uptake through the nuclear pore into the nucleus.
All the above considerations may account for the higher levels of in vivo gene transfer obtained with the smaller minicircles, than with unrecombined plasmid and larger constructs. However, other factors may be responsible for higher efficiency of minicircles. In particular, the immunostimulatory potency of bacterial immunostimulatory sequences containing CpG dinucleotides flanked by two 5′ purines and two 3′ pyrimidines might be important. These hexamers, which have been shown to affect gene expression by stimulating immunomodulatory cytokine [4] [5] [6] are 20 times more frequent in microbial than in mammalian genomes. 4 Such motifs are present more than a dozen times in the bacterial DNA backbone of pXL2776. Thus, the elimination of the bacterial DNA backbone in the minicircles might be partly responsible, by reducing inflammation and regeneration, for the higher levels of reporter gene expression in muscle. Finally, we cannot exclude a direct effect on transcription to explain the higher transgene expression observed with minicircles.
Since minicircles lack putative immunostimulatory sequences, they might be more suitable vectors for gene therapy than for DNA vaccines. On the other hand, their increased safety properties might be determinant for the extended use in large numbers of healthy subjects involved in vaccination.
The minicircles used in our experiments were purified 216 on density gradients which is not acceptable for clinical use. Wils et al 22 developed an affinity chomatography method for the purification of plasmid DNA, based on sequence-specific formation of a triple helix between immobilized oligonucleotides and a specific sequence present on the plasmid. This method could be used for large-scale production of minicircles. In conclusion, minicircles appear to be a promising tool for both in vivo and in vitro gene therapy strategies.
Materials and methods
Standard DNA manipulations All standard manipulations, including digestion with restriction enzymes, purification of DNA fragments by electroelution, DNA electrophoresis, E. coli transformation, purification of supercoiled DNA by CsCl-EtBr density gradient, and Southern blot analysis were performed as previously described. 23 Intermediate constructions of plasmids were used to transform E. coli DH5␣ (F − , 80lacZDM15, ⌬(lacZYA-argF)U169, deoR, recA1, endA1, hsdR17, phoA, supE44, l-thi-1, gyrA96, relA1) (Clontech Laboratories, Palo Alto, CA, USA). DNA concentration was measured by reverse phase HPLC analysis, using a Poros R2/H column (100 × 4.6 mm; PerSeptive Biosystems, Cambridge, MA, USA) followed by UV absorbance at 260 nm, as previously described. 22 Restriction enzymes and T4 DNA ligase were purchased from New England Biolabs (Beverly, MA, USA), Gibco-BRL (Life Technologies, Cergy Pontoise, France) or Amersham (Amersham, Les Ulis, France).
Plasmid construction pXL2776 was constructed from pXL2675, described by Wils and Ollivier in 1996 (patent reference FR 9603519): the minimal attB site 7 was inserted between the HindIII and SacI sites, and the attP site (position 27480 to 27860 in the published sequence of Sanger et al 24 ) was inserted between the XbaI and NsiI sites. Thus, pXL2776 contained a multiple cloning site between the attP and attB sites in the same orientation, and a kanamycin expression cassette. It was used as a vector for further cloning.
pXL3072 consisted of the pUC19 backbone linearized by digestion with PstI and XbaI 25 into which the following fragments were inserted: (1) an XbaI-HindIII fragment containing the human cytomegalovirus enhancer/ promoter (CMV) and the herpes simplex thymidine kinase (tk) gene 5′ untranslated leader; 26 (2) a HindIII-XbaI fragment containing the cDNA encoding the modified firefly luciferase (luc+) from pGL3 Basic (Promega Corporation, Madison, WI, USA); and (3) a PstI-XbaI fragment containing the polyadenylation signal from the bovine growth hormone gene (PolyA bGH) produced by PCR from pCDNA3.1 (Invitrogen, Leek, The Netherlands).
The 2.6 kb StuI-CMVtk/luc+/PolyA bGH-EcoRI fragment of pXL3072 was inserted between the EcoRV and EcoRI sites of pXL2776, giving plasmid pXL3186 (Figure 1) .
A plasmid was constructed from pCMV␤ (Clontech Laboratories) by removing the XhoI-splice donor/splice acceptor-SmaI fragment, converting the 5′-overhang of XhoI to a blunt end with the Klenow polymerase 23 and religating the resultant DNA fragment. The 4.3 kb EcoRI-␤-gal-HindIII fragment of this new plasmid was inserted between the EcoRI and HindIII sites of pXL2776, giving plasmid pXL3187. In this plasmid, the ␤-galactosidase (␤-gal) gene was under the control of the immediate-early human CMV enhancer/promoter and a simian virus polyadenylation signal (Figure 1) .
The SV40 luc minicircle (3.4 kb), plasmid pGL2 control (6 kb) (Promega Corporation), plasmid pXL2650 (7.4 kb) and plasmid pXL3067 (15.3 kb) , which contain the same SV40-luc expression cassette, have been described. 1 Production and purification of the CMV luc+ and CMV ␤-gal minicircles Bacteria were grown at 30°C in LB medium containing 50 mg/ml kanamycin. Plasmids 3186 and 3187 were used to transform E. coli strains D1210 (F − hsdS20, supE44, ara-14, galK2, proA2, leuB6, rpsL20, xyl5, mtl1, recA, mcrB, ⌬(mcrC-mrr), lacI Q ) 27 and D1210HP (D1210 lysogenized with cI857 xis − kil − phage). The phage lytic cycle was initiated in D1210HP cultures by incubation for 10 min at 42°C, which caused site-specific recombination, leading to the production of a minicircle and a miniplasmid. The miniplasmid consisted mostly of the original plasmid with the reporter gene expression cassette deleted. Extrachromosomal DNA in these cells was purified using standard plasmid DNA purification techniques 23 with a CsClEtBr density gradient. The purified DNA was then digested with MscI and BglII (pXL3187) or with AlwNI and BglII (pXL3186). A second density gradient was used to separate the CMV luc+ minicircle or CMV ␤-gal minicircle from the linearized miniplasmid and from linearized pXL3186 or pXL3187 (Figure 1) . Expression of plasmid DNA varies according to a large number of variables including differences between different preparations. 28 Thus, we had prepared different batches of plasmid and minicircle, which had been pooled in order to decrease the variability introduced by individual preparation.
CMV luc+ minicircle and CMV ␤-gal minicircle preparations were analyzed by Southern blotting. The 967 bp PvuII-BspHI fragment from pXL2776, the 2.6 kb StuIEcoRI fragment of pXL3072, and the 4.3 kb EcoRI-HindIII fragment of pXL3187 were 32 P-labeled using the Rediprime kit (Amersham, Les Ulis, France).
In vitro gene transfer Two cell lines were studied: NIH3T3 cells (murine fibroblasts; ATCC, Rockville, MD, USA) and rabbit primary aortic smooth muscle cells (RSM) obtained as previously described. 29 Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco-BRL) containing 100 units/ml penicillin, 100 units/ml streptomycin, 20 mm l-glutamine, and 10% bovine serum (NIH3T3) or 20% fetal calf serum (RSM) (Gibco-BRL) at 37°C, in a 5% CO 2 humidified atmosphere. For transfection, confluent cells were treated with trypsin and used to seed 24-well microtiter plates at about 50 000 cells per well. Cells were transfected 18 h after seeding, at 60-80% confluence. 30, 31 diluted in water, and of supercoiled DNA diluted in 150 mm NaCl, were mixed and incubated for 10 min at 20°C. The total amount of DNA added to each well was adjusted to 1 g with pBluescript KS II (Stratagene Cloning System, La Jolla, CA, USA) for each well. Cells were washed twice with serum-free medium before transfection. Transfections were performed in 500 l of serum-free medium by adding 50 l of the lipid/DNA mixture to each well. Each transfection experiment was performed in triplicate. Two hours after transfection, serum was added to a final concentration of 10% for NIH3T3 and 20% for RSM cells. Luciferase or ␤-galactosidase activity was assayed 48 h later.
Cells were incubated for 30 min with lysis buffer (25 mm Tris-phosphate, pH 7.8, 2 mm dithiothreitol, 2 mm 1,2 diaminocyclohexane-N, N, N′, N′-tetraacetic acid, 10% glycerol, and 1% Triton X-100) (200 l per well). The cells were removed by scraping and the lysate centrifuged. Luciferase activity was determined using the Luciferase Assay System (Promega), and ␤-galactosidase activity was measured using the luminescent ␤-galactosidase Genetic Reporter System II according to the manufacturer's recommendations (Clontech Laboratories). A LUMAT LB 9501 luminometer was used (Berthold, Evry, France). Cumulative light emission was measured for 5 or 10 l of supernatant over 10 s and was expressed in relative light units (RLU). The protein concentrations of the samples were determined using the Pierce BCA assay (Interchim, Asnières, France). 32 Results are expressed in RLU/g protein ± standard deviation.
In vivo gene transfer
Wolff et al 33 showed that TE inhibits expression of genes transferred into muscle. Thus, we dialyzed the DNA used for transfection in vivo against 150 mm NaCl. We used the cranial tibial muscles of 6-week-old C57BL6 mice for experiments with pXL3186 and the CMV luc+ minicircle. Six-week-old transgenic lacZ mice 34 were used for experiments with pXL3187 and the CMV ␤-galactosidase minicircle. In these lacZ transgenic mice, the lacZ gene is under the control of a H-2 (a major histocompatibility complex class I gene) promoter. The fusion gene does not lead to expression in muscle.
For pXL2650, pGL2 control and the SV40 luc minicircle, all of which contain the SV40 luc expression cassette, we used the cranial tibial muscles of C57BL6 mice, or tumors induced by grafting TU182 cells in nude mice. TU182 cells (human head and neck squamous carcinoma cells) were a gift from Dr Richard J Cristiano (MD Anderson Cancer Center, Houston, TX, USA). Tumors were induced on the flanks of nude mice by subcutaneous injection of 10 7 TU182 cells in the exponential phase of growth. Tumors were detected by palpation after 2-3 weeks. They were injected with DNA constructs when they reached a volume of around 100 mm 3 . Mice were anesthetized by intraperitoneal injection with 0.25 ml of a mixed solution of ketamine (85.8 mg/kg) and xylazine (3.1 mg/kg) in 0.9% NaCl. Minicircle or plasmid DNA, which had been dialyzed against 150 mm NaCl, was injected into the cranial tibial muscle or the tumor, in a single injection of 25 l, which contained 10 g of DNA.
Animals were killed by cervical dislocation. Tumors were removed 2 days after intratumoral injection. Muscles were removed 7 days (␤-galactosidase cassette) or 3 days (luciferase cassette) after intramuscular injection. The peak for luciferase expression in mice cranial tibial muscle occurred at the same time as reported in previous studies, 35 3 days after injection (data not shown).
For evaluation of reporter gene activity by chemiluminescence, muscles or tumor nodules were placed into Eppendorf tubes with 750 l lysis buffer containing Complete Protease Inhibitor Cocktail (Boehringer Mannheim, Meylan, France) and minced finely with scissors. Samples were incubated for 30 min on dry ice, homogenized (Ultra-Thurax Diax600 Heidolph) for 1 min and centrifuged at 12 000 g for 5 min at 4°C. Luciferase activity and ␤-galactosidase activity were measured as described for in vitro transfection samples, using 10 l of supernatant. The RLU were measured over 10 s. Results were normalized to total muscle or tumor volume.
Histological studies
The cranial tibial muscles of the mice were harvested 7 days after DNA injection, fixed for 4 h in 3.7% formalin in PBS, embedded in paraffin and 5 m sections were cut. The paraffin was removed, sections were rehydrated and treated for immunohistochemistry. They were blocked in 10% bovine serum albumin for 30 min and incubated with a 1:500 dilution of polyclonal rabbit anti-mouse luciferase antibody (Europa Research Products/Cortex Biochem, San Leandro, CA, USA) for 1 h at 37°C. Sections were washed three times with PBS gelatin, and a 1:200 dilution of the secondary antibody biotinylated anti-rabbit IgG solution (Amersham) was added. The sections were incubated with a 1:400 dilution of avidin-biotin peroxidase complex (Amersham) and the reactions were detected with diaminobenzidine. All sections were counterstained in haematoxylin, dehydrated and mounted in Permount.
